Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tretinoin With or Without Oral Fenretinide in Dysplastic Nevus Syndrome
NCT00003601Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Feb 1999
- Primary completion
- Mar 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenretinide in dysplastic nevus syndrome (DNS), sponsored by Eastern Cooperative Oncology Group. Started Feb 1999; status: completed.
02
Drugs
fenretinide
03
Conditions
dysplastic nevus syndrome (DNS)
Beyond the preview
Go deeper on NCT00003601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003601.